ILC3s control airway inflammation by limiting T cell responses to allergens and microbes.

TitleILC3s control airway inflammation by limiting T cell responses to allergens and microbes.
Publication TypeJournal Article
Year of Publication2021
AuthorsTeng F, Tachó-Piñot R, Sung B, Farber DL, Worgall S, Hammad H, Lambrecht BN, Hepworth MR, Sonnenberg GF
JournalCell Rep
Volume37
Issue8
Pagination110051
Date Published2021 11 23
ISSN2211-1247
KeywordsAdaptive Immunity, Allergens, Animals, Asthma, CD4-Positive T-Lymphocytes, Cytokines, Female, Host Microbial Interactions, Humans, Immunity, Innate, Inflammation, Lung, Lymph Nodes, Lymphocytes, Male, Mice, Mice, Inbred C57BL, Pyroglyphidae, Respiration, Respiratory Hypersensitivity, Th17 Cells, Th2 Cells
Abstract

Group 3 innate lymphoid cells (ILC3s) critically regulate host-microbe interactions in the gastrointestinal tract, but their role in the airway remains poorly understood. Here, we demonstrate that lymphoid-tissue-inducer (LTi)-like ILC3s are enriched in the lung-draining lymph nodes of healthy mice and humans. These ILC3s abundantly express major histocompatibility complex class II (MHC class II) and functionally restrict the expansion of allergen-specific CD4+ T cells upon experimental airway challenge. In a mouse model of house-dust-mite-induced allergic airway inflammation, MHC class II+ ILC3s limit T helper type 2 (Th2) cell responses, eosinophilia, and airway hyperresponsiveness. Furthermore, MHC class II+ ILC3s limit a concomitant Th17 cell response and airway neutrophilia. This exacerbated Th17 cell response requires exposure of the lung to microbial stimuli, which can be found associated with house dust mites. These findings demonstrate a critical role for antigen-presenting ILC3s in orchestrating immune tolerance in the airway by restricting pro-inflammatory T cell responses to both allergens and microbes.

DOI10.1016/j.celrep.2021.110051
Custom 1

https://www.ncbi.nlm.nih.gov/pubmed/34818549?dopt=Abstract

Alternate JournalCell Rep
PubMed ID34818549
PubMed Central IDPMC8635287
Grant ListR01 AI162936 / AI / NIAID NIH HHS / United States
R21 CA249274 / CA / NCI NIH HHS / United States
P01 AI106697 / AI / NIAID NIH HHS / United States
R01 AI145989 / AI / NIAID NIH HHS / United States
R01 AI123368 / AI / NIAID NIH HHS / United States
/ WT_ / Wellcome Trust / United Kingdom
R01 AI143842 / AI / NIAID NIH HHS / United States
U01 AI095608 / AI / NIAID NIH HHS / United States
105644/Z/14/Z / WT_ / Wellcome Trust / United Kingdom
BB/T014482/1 / BB_ / Biotechnology and Biological Sciences Research Council / United Kingdom

Weill Cornell Medicine Gale and Ira Drukier Institute for Children's Health 413 E. 69th Street New York, NY 10021